Page 1

Genetic Signatures ASX Announcement 25 October 2021 Quarterly Activities Report and Appendix 4C Highlights • Record quarterly sales revenue of $ 12.4 million Positive cash quarter - $ 2.9m • Receipts from customers in 1Q FY22 was $ 10.3 million • Cash balance at 30 September $ 33.0 million and no debt • Current quarter continues the strong sales performance Genetic Signatures Limited ( ASX : GSS ) today provided an update on operating activities for the quarter ended 30 September 2021 . The business recorded its highest ever quarterly revenue with sales of $ 12.4 million , an increase of 129 % over the previous quarter ( 4Q FY21 ) and an 18 % increase over the prior corresponding quarter ( 1Q FY21 ) . Receipts from customers increased to $ 10.3 million . Figure 1 : GSS Qtrly revenue ( A $ m ) 28.3 5.4 4.2 8.2 12.4 11.3 7.0 4.9 12.4 10.5 1.5 1.8 1.1 1.0 1.2 1.0 1.5 FY19 FY20 FY21 FY22 ■ Q1 Q2 Q3 Q4